young-professional-team-discussing-business-plan-i-2022-02-02-21-53-56-utc-scaled-e1657877

Calypte

business-people-shake-hands-in-the-office-e1655897424318.jpg

More About Us

We Like to Meet Entrepreneurs

While we invest at Series A (generally, when a company is over $2M in revenue), we like to meet founders before they’re raising their Series A – to build a relationship, learn more about the company, and allow them to get to know us. Please do reach out.

ABOUT US

New Markets Team

Mark Grovic

Co-Founder and General Partner

Follow Us On

Status

Realized

Location

Visit

Calypte Biomedical Corporation develops innovative in vitro diagnostic testing solutions for HIV and other infectious diseases. Calypte Biomedical Corporation’s reliable, non-invasive HIV diagnostic tests and specialty research tools are helping doctors and scientists improve health and health care around the world.